Oaktree Capital Management has been following a mantra of “move forward, but with caution,” since 2011, and Howard Marks, the firm’s chairman, told AVCJ earlier this year that he has seen no reason to change this outlook
"I haven't thought that the outlook is so bad or prices so high that we can't make or hold investments, but I also thought that it was extremely important to be cautious, careful and conservative in this...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.